Agency of the United States Department of Health and Human Services
POPULARITY
Categories
357 episodes with fda
281 episodes with fda
183 episodes with fda
247 episodes with fda
229 episodes with fda
126 episodes with fda
183 episodes with fda
112 episodes with fda
147 episodes with fda
150 episodes with fda
273 episodes with fda
183 episodes with fda
178 episodes with fda
185 episodes with fda
53 episodes with fda
82 episodes with fda
75 episodes with fda
90 episodes with fda
65 episodes with fda
62 episodes with fda
135 episodes with fda
55 episodes with fda
70 episodes with fda
107 episodes with fda
107 episodes with fda
61 episodes with fda
68 episodes with fda
36 episodes with fda
96 episodes with fda
44 episodes with fda
50 episodes with fda
65 episodes with fda
44 episodes with fda
42 episodes with fda
105 episodes with fda
43 episodes with fda
64 episodes with fda
50 episodes with fda
47 episodes with fda
51 episodes with fda
61 episodes with fda
97 episodes with fda
78 episodes with fda
41 episodes with fda
38 episodes with fda
59 episodes with fda
64 episodes with fda
56 episodes with fda
55 episodes with fda
97 episodes with fda
73 episodes with fda
59 episodes with fda
49 episodes with fda
99 episodes with fda
In this episode, Anders Varner, Doug Larson, and Travis Mash sit down with Matt Brown, Director of Business Development at Springbok Analytics, to explore the cutting edge world of MRI based muscle analysis. Matt breaks down the origins of Springbok, how the company grew from a university research lab solving cerebral palsy surgical problems into one of the most advanced muscle segmentation platforms on the planet, and why professional sports teams, medical researchers, and longevity practitioners are all adopting this technology. From 15 minute full body protocols to AI driven segmentation of 144 muscles, Springbok is redefining what is possible in muscle profiling and objective performance measurement. The conversation dives into real world application, how Springbok helps pro athletes understand tissue quality, fat infiltration, tendon health, asymmetries, compensations, and injury risk with unprecedented precision. Matt shares examples across the NBA, NFL, soccer, and clinical research showing how MRI data is being used to shorten rehab timelines, guide targeted strength work, map scar tissue, and track atrophy after major injuries like ACL tears. The group contrasts traditional tools like DEXA with what is now possible using MRI, individualized baselines, normative values by sport and position, and 3D interactive models that reveal exactly where muscle is strong, weak, or compromised. Finally, the team covers the massive opportunity in longevity and consumer health. They discuss how muscle quality predicts aging trajectories, why fat infiltration accelerates decline, and how Springbok's new FDA cleared body composition capabilities unlock deeper insights into visceral fat, liver fat, bone density, and long term risk. Doug outlines how Rapid Health Optimization is partnering with Springbok through Optima Muscle to bring these pro level analytics to everyday people, combining MRI data with elite coaching, physical therapy, and strength programming to create personalized, actionable plans that maximize performance and minimize injury. This episode is a powerful preview of where the future of muscle health, performance diagnostics, and longevity is headed. Learn more at: OptimaMuscle.com Links: Barbell Shrugged on Instagram Springbok Analytics on Instagram Anders Varner on Instagram Doug Larson on Instagram Coach Travis Mash on Instagram
About this episode: Robotic telesurgery allows providers to conduct minimally invasive surgeries across long distances, reaching remote communities. In this episode: Binita Ashar, a surgeon with a background in policy, discusses the revolutionary role this technology can play in medicine and what issues need to be addressed—from cost to cybersecurity—in order to greenlight more procedures in the United States. Guests: Binita Ashar, MD, MBA, is a general surgeon who previously served as the Director of the FDA's Office of Surgical and Infection Control Devices. She also serves on the board of the Society of Robotic Surgery. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Exclusive look at groundbreaking remote robotic surgery: Patient was in Africa; doctor was in Florida—ABC News WHO and Society of Robotic Surgery launch health innovation initiative to expand access to virtual care and telesurgery—WHO Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @PublicHealthPod on Bluesky @JohnsHopkinsSPH on Instagram @JohnsHopkinsSPH on Facebook @PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
In this episode, Jess and Sarah welcome Dr. Joe Schwarcz, a renowned chemist and science communicator, to explore a range of current scientific topics. The scientists discuss a recent infant formula recall and the FDA's removal of black box warnings from estrogen products, providing context for these regulatory decisions. Dr. Schwarcz addresses the complexities of nutrition research, debunking common misconceptions about superfoods and food additives while emphasizing the importance of understanding food safety. Throughout the conversation, the experts examine the challenges of effective science communication in an era of widespread misinformation. The episode underscores the critical need for improved public science education and clearer communication strategies to help people navigate complex health and safety information in their daily lives. Video available on YouTube: https://youtu.be/0kvnw6eE_2I (00:00) Intro and Public Health Update (03:41) What Is A News Item That Caught Your Attention And Why? (Removing Black Box Warning From Estrogen Products) (07:45) The Problem With The Blanket Approach To Ultraprocessed Foods (11:47) Better Not Burn Your Toast - Dr Joe's New Book (15:29) The Importance (And Challenge) Of Science Communication (22:39) Risk Approach Vs. Hazard Approach (26:51) Are SuperFoods Real? (30:45) What Is Giving Hope In Science And Public Health? https://ecwpress.com/products/better-not-burn-your-toast Better Not Burn Your Toast: The Science of Food and Health on Amazon ----------------------------------------------------------------------------------------------------------------------- Interested in advertising with us? Please reach out to advertising@airwavemedia.com, with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers. Learn more about your ad choices. Visit megaphone.fm/adchoices
This week, trauma expert Dr. Aimie Apigian is here to change how we understand trauma. She shares how becoming a foster parent led her into trauma healing—and y'all, her story is powerful. Dr. Aimie explains the difference between stress and trauma, reveals how our bodies hold onto past experiences, and offers practical steps for us to start releasing them. Get ready for real talk, actionable tools, and hope—this episode is for all of us ready to heal from the inside out.In this episode:How becoming a foster parent shaped Dr. Amie's path to becoming a trauma expertThe three qualities shaped by trauma responsesHow the body recognizes and stores traumaCommon patterns of stored trauma in the bodyActionable steps to begin healing trauma in the bodyHere is my favorite quote from this episode:"The body does not allow us to leave our past in the past." - Dr. Aimie ApigianExperience Bible Life Guides: Forgiven and Free — a 21-day Bible-based journey to emotional freedom, available free at https://try.biblelifeguides.com/products/forgiven-free-with-kim-gravelTake the Quiz: Which Maribelle and the Manger character are you? Find out here: https://bit.ly/4pxUqF8If you want your questions answered then leave a comment or call me and leave me a voicemail at 404-913-6460There is BONUS CONTENT in our free newsletter so make sure to subscribe at https://www.kimgravelshow.comNEW! Order Kim's Holiday Children's BookEmbark on a magical adventure with five friends as they journey together to witness the birth of Jesus! It's a heartwarming holiday tale your whole family will love.Kim's brand-new storybook Maribelle and the Manger is available now: https://maribelleandthemanger.com/?utm_source=lwya.beehiiv.com&utm_medium=newsletter&utm_campaign=pre-order-kim-s-new-book&_bhlid=075a4287c5257cbe2d43cc23e857262cc9cf39cdConnect with Dr. Aimie Apigian:InstagramLinkedInYouTubeWebsitePodcast: The Biology of TraumaBook: The Biology of TraumaConnect with Me:YouTubeFacebookInstagramTikTok WebsiteNew episodes of The Kim Gravel Show drop every Wednesday at 6pm EST.Support our show by supporting our Sponsors:Aura FramesThe holidays are almost here, and Aura Frames is the gift that brings memories to life. Aura is a digital photo frame with unlimited storage that can be updated instantly from any phone, anywhere. It's an easy way to share moments, keep traditions alive, and feel connected every day. You can't wrap togetherness, but you can frame it.For a limited time, visit https://on.auraframes.com/KIM and get $45 off Aura's best-selling Carver Mat frame with promo code KIM at checkout. This exclusive Black Friday/Cyber Monday offer is their best of the year—order before it ends!HERSMenopause can bring hot flashes, fatigue, brain fog, and other challenging symptoms—but getting help doesn't have to be hard. HERS now offers menopause care through their trusted online health platform. Complete a simple medical intake, and if eligible, a licensed provider creates a personalized treatment plan with access to FDA-approved options. Many women start feeling relief in 4–6 weeks, with better sleep, fewer hot flashes, and improved overall well-being.Visit https://www.forhers.com/kim to get a personalized plan. Not available in all 50 states. Perimenopause & Menopause by Hers includes hormonal health support, educational resources, digital tools, and prescription options, if appropriate. See website for full details, important safety information, and restrictions.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
On this episode of Vitality Radio, Jared opens part one of a powerful new series on what he calls the hidden epidemic—the widespread and silent impact of endocrine-disrupting chemicals (EDCs) on hormones, brain chemistry, metabolism, and long-term health. After more than a year and a half of deep research, Jared and his wife Jen have uncovered how these chemicals mimic hormones, block receptors, interfere with detox pathways, disrupt neurotransmitters, and contribute to challenges like fatigue, low motivation, stubborn weight gain, PMS, anxiety, sleep struggles, and declining testosterone in both men and women.This episode explains why the endocrine system is struggling more than ever, how EDCs create thyroid chaos, hormonal imbalance, and neurochemical disruption, and what steps you can begin taking right now to start clearing these compounds from your environment and your body. If you've been dealing with symptoms that “don't match” your lab work, if you've struggled to feel balanced despite doing the right things, or if you've suspected environmental chemicals may be affecting you or your family, make sure to listen to Part 2 and stay tuned for future episodes. This is a big issue, but there are real answers and we are bringing them to you very soon on Vitality Radio.Products:LiverVitalityEndoCleanseBack On TractVital D3/K2Source Naturals Nattokinase 50mg - Vitality Radio POW! Product of the Week $11.99 per bottle (almost 70% off) with PROMO CODE: POW18Additional Information:Vitamin K2 and the Calcium Paradox: How a Little-Known Vitamin Could Save Your Life by Dr. Kate RhéaumeVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
Stem cells and exosomes continue to shape conversations in the medical aesthetics and wellness industry, but understanding what is legally allowed is just as important as understanding the science. In this episode, Dr. Jordan Plews, PhD, a scientist and entrepreneur in biotechnology and stem cell research, breaks down how these products work and the regulatory challenges surrounding them. Tune in to understand how medical practices can legally use these products and the risks of going off-label or using unapproved treatments.Chapters00:00 Intro00:47 Banter 07:16 Tell us about you and your background.09:21 Jordan, can you please explain what stem cells and exosomes are?12:38 Is there a product out there that is similar to stem cells?15:12 Asking for a Friend. Our first question we are asking for a friend, is for someone who is an owner of an aesthetic practice, and they are interested in treating patients with stem cells or exosomes. From your perspective, can a medical practice offer stem cells or exosomes?20:16 Talk about the risk patients and providers are taking on when they go down that road.22:53 What would you advise clients that are thinking about adding these products into their practice?26:33 Access+27:09 Legal Takeaways30:09 OutroWatch full episodes of our podcast on our YouTube channel: https://www.youtube.com/@byrdadattoStay connected for the latest business and health care legal updates:WebsiteFacebookInstagramLinkedIn
The FDA just made history, and it changes everything for women's health. After 23 years, the FDA removed the black box warning from estrogen therapy. This is a MASSIVE win for women everywhere. What we were told about estrogen being risky for breast cancer, stroke, and heart attack? Completely inaccurate. We'll soon break down what this means for you, and why testosterone therapy for women is next. In the meantime, here are the TOP 5 MOMENTS FROM MENOPAUSE MASTERY: 1️⃣ 5 Dietary Changes to Get Rid of Meno Belly The foundation matters more than the biohacks. Here are 5 dietary changes that reduce visceral fat, improve insulin sensitivity, and lower disease risk.
As we head into the busy holiday season, we're talking about something we all want-healthy, glowing skin that reflects how good we feel inside. Meet my latest guest Autumn Groscost, a certified physician assistant who practices with St. Clair Medical Group Plastic Surgery. Autumn shares how you can feel your best from the inside out and the importance of self-care even when life gets hectic. In this episode, we discuss some of the most well-known aesthetic treatments and how they can help your complexion stay bright through the busy holiday season. From neuromodulators like Botox and Juveau, to dermal fillers and the FDA‑approved SkinPen microneedling, we cover practical timelines for treatments and their natural, confidence‑boosting results. If your interested in learning more or want to schedule a personalized consultation with Autumn visit https://physicians.stclair.org/scmg-plastic-surgery/ Thank you St. Clair Health for partnering with me to bring valuable information from medical experts outside the exam room. All episode are available on all the major audio platforms. As well as Jenny D.'s YouTube channel. Make sure to Subscribe and Follow. http://www.youtube.com/@Spillwithmejennyd If you want like to be guest or a sponsor on Spill with Me Jenny D. Show contact Kelli Komondor at kelli@k2creativellc.com To view previous episodes and fill out a disclaimer to be a guest under Tell us Your Story visit https://www.spillwithmejennyd.com/
This week on Swimming with Allocators, Jay Rongjie Wang, Founder and CEO of Primitiva Global, shares her journey from her pioneering upbringing shaped by her mother's tech entrepreneurship to becoming a leading venture investor bridging Silicon Valley, Hong Kong, and Shanghai. Jay discusses the importance of authenticity and “congruence” in investment decisions, her “impossible triangle” theory for evaluating AI opportunities, and cross-border fundraising strategies. Listeners will gain actionable insight into aligning personal strengths with business practices, understanding global LP/GP dynamics, and balancing boundless curiosity with focused execution in the rapidly evolving world of tech and venture capital. Also, don't miss our insider segment as Idan Netser and Jason Kropp from Sidley discuss key tax incentives for venture funds, including carried interest treatment and Qualified Small Business Stock benefits, as well as recent FDA regulatory changes impacting biotech and medtech startups, offering timely guidance for VC investors and founders.Highlights from this week's conversation include: Welcoming Jay to the Episode (0:22) Impact of Parenting on Risk, Creativity, and Early Career Choices (5:24) Lessons Learned from Running Community Website: Career Preparation (7:17) Discussion of Gender Dynamics, Over-Preparation, and Confidence (10:00) Traits for Successful Fund Managers: Concept of Congruence (11:38) Practical Framework for Identifying "Winner Energy" and Reference Checks (17:55) Consistency in Feedback About GPs (21:46) Regulatory Topics: Carried Interest, Tax, and FDA Insights (23:54) Energy Management, Executive Capacity, and Inner Focus (28:48) Impossible Triangle Theory on AI Progress and Investment Filtering (30:27) Applying the Theory: GPU and Data Center Investments (36:06) Fundraising Successes Outside the US and Motivations of International LPs (39:09) Balancing Curiosity with Focus for Investors (41:20) Personal Advice on Career Methodology and Venn Diagram Specialization (44:24) Final Thoughts and Takeaways (45:15) Primitiva Global is a family office and investment platform operating across Silicon Valley and Hong Kong. Primitiva backs first-check venture managers and invests in companies expanding the frontiers of artificial intelligence, deep technology, and global innovation. The firm combines deep research, top-down analysis, and hands-on partnership to support the next generation of builders and allocators. Learn more at www.primitivaglobal.com Sidley Austin LLP is a premier global law firm with a dedicated Venture Funds practice, advising top venture capital firms, institutional investors, and private equity sponsors on fund formation, investment structuring, and regulatory compliance. With deep expertise across private markets, Sidley provides strategic legal counsel to help funds scale effectively. Learn more at sidley.com. Swimming with Allocators is a podcast that dives into the intriguing world of Venture Capital from an LP (Limited Partner) perspective. Hosts Alexa Binns and Earnest Sweat are seasoned professionals who have donned various hats in the VC ecosystem. Each episode, we explore where the future opportunities lie in the VC landscape with insights from top LPs on their investment strategies and industry experts shedding light on emerging trends and technologies. The information provided on this podcast does not, and is not intended to, constitute legal advice; instead, all information, content, and materials available on this podcast are for general informational purposes only.
This is a free preview of a paid episode. To hear more, visit meetthemess.substack.comMove over, Meet the Press—it's time to MEET THE MESS!This week on the podcast, Jen and Karyn are back! The House voted to release the Epstein files, but will it actually happen? Meanwhile, Trump delivers a completely bananas speech to McDonald's franchise owners and tells a female reporter, “Quiet, piggy.”Also on deck: a behavioral scientist breaks down what it means when someone does (or doesn't) return their cart. Plus, Kim Kardashian fails the bar exam, the FDA removes the black box warning from menopause hormone therapy, and a flamingo escapes a British zoo and decides to retire on a beach in the south of France. And finally, do you have a preferred font?On Meet the Mess, bestselling authors Jen Lancaster & Karyn Bosnak dive into the messiest news stories and hottest topics of the week to give a fresh and entertaining take on current events and life in general. An extended video version with the “Hot Mess of the Week” is available to paid Substack subscribers. Visit meetthemess.substack.com for more.Meet the Merch:• https://www.etsy.com/shop/MeetTheMessConnect with us on Instagram:• https://www.instagram.com/meetthemesspod• https://www.instagram.com/jennsylvania• https://www.instagram.com/karynbosnakConnect with us on TikTok:• https://www.tiktok.com/@meetthemess• https://www.tiktok.com/@karynbosnak
In this video, I'm diving into a question I'm asked all the time — should women use male testosterone products? The answer might surprise you. Testosterone therapy can be a safe and effective treatment for Hypoactive Sexual Desire Disorder (HSDD) and other symptoms of low testosterone in women — but the key lies in dose, delivery method, and medical supervision. I'll walk you through: • The science behind testosterone in women and why it matters for sexual health, energy, and well-being • The difference between FDA-approved male testosterone products and compounded testosterone gels or creams commonly prescribed for women • How dosage adjustments are made for female physiology • A real-life demonstration on how to correctly use topical testosterone products • Important considerations for safety, absorption, and hormone balance It's not about “male vs. female” testosterone — it's about finding the right form and dose to restore optimal function and vitality. Medical Insight: Testosterone is a crucial hormone in women too — affecting libido, bone density, muscle mass, and overall mood. Low levels can contribute to fatigue, loss of desire, and decreased quality of life. As always, hormone therapy should be personalized and physician-guided.
Interim CEO of ASCP and host Dr. Ali Brown sits down with Dr. Eric Konnick and Michelle Campbell, MLS(ASCP) to discuss lessons learned from the latest efforts to place laboratory developed tests under FDA oversight. For listeners unfamiliar with LDTs, they begin by establishing what LDTs are and what their value to the lab and patient safety are before debunking common misunderstandings cited by patient advocacy groups regarding their accuracy, validity, and the transparency with which they're developed. They go on to define what FDA oversight would mean for laboratories in terms of cost, time, and labor, contextualizing these added costs in ongoing workforce shortages in the lab. They close their conversation by spotlighting which efforts ASCP and similar organizations made to advocate for the lab were most successful, and describe alternative strategies for updating laboratory regulations, such as modernizing CLIA.
In this episode, Dr. Allyson Brooks, the Ginny Ueberroth Executive Medical Director Endowed Chair of the Hoag Women's Health Institute, discusses how Hoag is transforming menopause care through multidisciplinary collaboration, education, and community engagement. She shares how the FDA's recent hormone therapy update and women's growing advocacy are reshaping the future of midlife health.
In this episode, Dr. Allyson Brooks, the Ginny Ueberroth Executive Medical Director Endowed Chair of the Hoag Women's Health Institute, discusses how Hoag is transforming menopause care through multidisciplinary collaboration, education, and community engagement. She shares how the FDA's recent hormone therapy update and women's growing advocacy are reshaping the future of midlife health.
Jackie takes a well earned deep breath following the completion of the Dim the Lights tour, rails against the glorification of tinned fish, and advises against combining bodily fluid colors in an outfit.Thanks for supporting my sponsors:Home Chef: For a limited time, get 50% off and free shipping for your first box. Plus free dessert for life at www.HomeChef.com/BIBLENutrafol: For a limited time, get $10 off your first month's subscription and free shipping at www.nutrafol.com/biblePique: Get up to 20% off for life, plus a complimentary gift at www.PiqueLife.com/BIBLEAddyi: Check out the FDA-approved treatment for certain premenopausal women who are bothered by low libido and want their sex drive back at www.Addyi.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The FDA is planning to remove the “black box” warning from many hormone treatments for menopause -- a major shift that could change care for millions of women in this country. On this week's Paging Dr. Gupta, we break down what who this treatment could help and what you still need to know about its risks. This episode was produced by Jennifer Lai with assistance from Kyra Dahring and Leying Tang. Showrunner: Amanda Sealy Senior Producer: Dan Bloom Technical Director: Dan Dzula Executive Producer: Steve Lickteig Learn more about your ad choices. Visit podcastchoices.com/adchoices
In this episode of The President's Daily Brief: Newly uncovered emails reveal Jeffrey Epstein's sprawling network of foreign contacts — and his extraordinary claims that he was feeding Russian associates insight into Donald Trump's policy decisions. Poland deploys security forces after a critical rail line to Ukraine is blown up in what officials are calling a suspected act of sabotage. Plus — thousands of demonstrators in Mexico City clash with police during protests over cartel violence and government inaction. And in today's Back of the Brief — a notorious Ecuadorian drug kingpin who faked his own death has finally been captured in Spain, ending four years on the run. To listen to the show ad-free, become a premium member of The President's Daily Brief by visiting https://PDBPremium.com. Please remember to subscribe if you enjoyed this episode of The President's Daily Brief. YouTube: youtube.com/@presidentsdailybrief Rugiet: Ready to give Rugiet a try? Get 15% off your first order by going to http://rugiet.com/PDB and using code PDB. Rugiet prescriptions are compounded medications, available only if prescribed following an online consultation with a licensed clinician. Compounded drugs can be prescribed by federal law, but are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or manufacturing. Individual results may vary. Full safety information available at https://Rugiet.com Lean: Visit https://BrickhouseSale.comfor 30% off StopBox: Not only do you get 10% Off your entire order when you use code PDB10 at https://stopboxusa.com/PDB10, but they are also giving you Buy One Get One Free for their StopBox Pro. #stopboxpod Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode of The PDB Afternoon Bulletin: Russia's oil sector is taking heavy hits on two fronts. Ukrainian drones are striking deep inside the country, while new U.S. sanctions are cutting off key buyers in India and China. We'll explain why this dual pressure is becoming a serious problem for Moscow's war economy. Germany is preparing to lift its freeze on arms exports to Israel, saying the Gaza ceasefire has stabilized enough to reverse restrictions imposed during the height of the conflict. Please remember to subscribe if you enjoyed this episode of The President's Daily Brief. YouTube: youtube.com/@presidentsdailybrief Rugiet: Ready to give Rugiet a try? Get 15% off your first order by going to http://rugiet.com/PDB and using code PDB. Rugiet prescriptions are compounded medications, available only if prescribed following an online consultation with a licensed clinician. Compounded drugs can be prescribed by federal law, but are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or manufacturing. Individual results may vary. Full safety information available at https://Rugiet.com Lean: Visit https://BrickhouseSale.comfor 30% off StopBox: Not only do you get 10% Off your entire order when you use code PDB10 at https://stopboxusa.com/PDB10, but they are also giving you Buy One Get One Free for their StopBox Pro. #stopboxpod Learn more about your ad choices. Visit megaphone.fm/adchoices
Breaking down the food-pharma cartel—showing how tobacco giants, chemical processors, and billionaire foundations engineered addictive factory food, chronic illness, and a century of medical censorship. Richardson exposes how the Flexner takeover, Rockefeller petro-medicine, and FDA suppression of natural treatments like Laetrile created a monopolized sickness industry that profits from diabetes, cancer, and obesity while silencing dissent.Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.
What if everything you've been told about menopause is wrong? In this episode, I sit down with Dr. Mary Claire Haver — board-certified OB/GYN and leading menopause expert — to unpack the science reshaping women's health. We break down the FDA's recent removal of the 22-year black box warning on hormone therapy, why only 4% of women use HRT today, and how fear and misinformation have shaped decades of care. Dr. Haver also dives into the rise of menopause “biohacks,” from NAD and PRP to the fundamentals that truly move the needle: sleep, strength training, and metabolic health. Her message is simple: Menopause isn't a disease — it's a transition, and you deserve informed, evidence-based support. If you've ever felt dismissed or confused during midlife changes, this conversation will give you clarity, confidence, and the science to advocate for yourself. Follow Dr. Haver:Instagram: @drmaryclaireTikTok: @drmaryclaireWebsite: The Pause LifePre-order The New Perimenopause, set to release on April 7, 2026: https://thepauselife.com/pages/the-new-perimenopause-bookListen to Dr. Haver's podcast, unPAUSED, here: https://thepauselife.com/pages/the-unpaused-podcast *** Subscribe to The Neuro Experience for more conversations at the intersection of brain science and performance. I'm committed to bringing you evidence-based insights that you can apply to your own health journey. *** A huge thank you to my sponsors for supporting this episode. Check them out and enjoy exclusive discounts: TroscriptionsGive it a try at https://www.troscriptions.com/NEURO or enter NEURO at checkout for 10% off your first order. TimelineHead to https://www.timeline.com/neuro to get started. Branch BasicsHead to https://www.branchbasics.com and use code NEURO for 15% off. Hollow SocksFor a limited time Hollow Socks is having a Buy 3, Get 3 Free Sale. Head to https://www.ollowsocks.com today to check it out. Jones Road BeautyUse code NEURO at https://www.jonesroadbeauty.com to get a free Cool Gloss with your first purchase. *** I'm Louisa Nicola — clinical neurophysiologist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_***Topics discussed: 00:00 – Intro 01:55 – The FDA removed the “black box” warning for HRT 05:16 – The Social Media Effect on Menopause Education 07:54 – How Doctors Historically Dismiss Women's Symptoms 11:12 – Why So Many Women Get Antidepressants Instead of HRT 14:07 – Life Stress vs Hormone-Driven Symptoms 16:48 – The Timing Hypothesis / Critical Window Explained 19:06 – Why Modern RCTs Aren't Happening 20:10 – Proven Benefits: Bone Health & Osteoporosis Prevention 21:35 – HRT, Dementia, and Brain Health: What the Data Actually Shows 23:16 – Environmental Toxins, Brain Health & Midlife Risk Factors 25:24 – How the Internet Distorts Menopause Education 27:10 – The “Brain Eating Itself” Debate: The Real Science 30:09 – What Brain Fog Really Is During Perimenopause 32:24 – Why High-Functioning Women Struggle the Most 34:03 – Breast Cancer Risk: What the WHI Actually Found 35:00 – Why Sleep Is the First Line of Treatment Learn more about your ad choices. Visit megaphone.fm/adchoices
If you've ever hit a breaking point, the kind that forces you to stop pretending you're fine, this episode is medicine. Emily Fletcher sits down with actress and creative force Tati Gabrielle (You, Chilling Adventures of Sabrina, Kaleidoscope) to explore how pain becomes power when you're willing to meet it head-on. From depression in Atlanta to an identity unraveling to discovering a spiritual practice that rebuilt her from the inside out, Tati shares the raw moments that became her initiation into authenticity. This conversation isn't about bypassing pain, it's about alchemizing it. Turning the collapse into clarity. Turning the wound into wisdom. Turning the struggle into strength. In this episode, we explore: • How to recognize when pain is trying to redirect you • The morning ritual that helped Tati rebuild her life • The difference between numbing pain and transforming it • Why meditation can be a portal for emotional alchemy • The “mind palace” technique she used to rewire her future • How intuition becomes louder when you stop abandoning yourself • What inner child healing actually looks like in daily life • A more empowered way to relate to fate, free will, and resilience Timestamps: • [02:01] When everything broke open — Tati's turning point and the moment pain became her invitation inward. • [06:26] The 7 a.m. ritual that saved her — The simple, self-created practice that pulled her out of depression. • [10:06] Anxiety vs. soul alignment — How she learned to read her body and separate fear from intuition. • [12:18] The “red carpet” vision — The emotional anchor that fueled her transformation and early manifestation wins. • [17:38] The power pivot — How her internal shift created rapid external change (manager, agent, bookings). • [24:38] The body map of intuition — The clearest explanation of where intuition lives vs. where anxiety lives. • [32:49] Life as a video game — A reframe for navigating pain, destiny, and empowerment with play instead of pressure. • [40:57] Mini-resets that regulate the nervous system — The exact micro-practices Tati uses when she spirals. • [48:30] Inside the darkest moments — How she navigates panic, bipolar swings, and the instinct that brings her back. • [53:06] Acting as devotion — How she channels characters as real souls — and why creativity can be healing. Guest Links: • Follow Tati → @tatigabrielle • Watch Tati's work → Netflix: You, Chilling Adventures of Sabrina, Kaleidoscope • IMDb → imdb.com/name/nm5354727 More from Emily & Ziva: • Join Ziva Magic: makemagic.zivameditation.com • Learn Ziva Meditation: preview.zivameditation.com • Free Masterclass: learn.zivameditation.com • Get 15% off with promo code WHYTHIS: whythis.zivameditation.com • Follow on Instagram: @zivameditation • Visit upgradedformulas.com/emily and use code EMILY for 20% off everything at UpgradedFormulas.com. These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider if pregnant/nursing, on medication, or have a medical condition.
Breaking down the food-pharma cartel—showing how tobacco giants, chemical processors, and billionaire foundations engineered addictive factory food, chronic illness, and a century of medical censorship. Richardson exposes how the Flexner takeover, Rockefeller petro-medicine, and FDA suppression of natural treatments like Laetrile created a monopolized sickness industry that profits from diabetes, cancer, and obesity while silencing dissent.Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.
When conventional revascularization fails, can deep venous arterialization offer a new lifeline to limb salvage? Dr. Lucas Ferrer Cardona, vascular surgeon at Ascension and Dr. Miguel Montero Baker, vascular surgeon and medical director at HOPE Clinical Innovation Center join host Dr. Sabeen Dhand for an insightful discussion on deep venous arterialization (DVA). --- This podcast is supported by: RADPAD® Radiation Protectionhttps://www.radpad.com/ --- SYNPOSIS The doctors discuss the progression of deep venous arterialization, highlighting the benefits of open, endovascular, and hybrid approaches. They draw on their personal experiences to share key technical nuances and explore new devices such as the Aveera Boomerang device. They emphasize the critical role of patient selection, family support, and close postoperative surveillance, including weekly wound assessments and monthly ultrasound evaluations. Although currently FDA-approved for no-option chronic limb-threatening ischemia (CLTI), Dr. Baker notes that deep venous arterialization may hold promise even for patients earlier in the disease course.The episode concludes by exploring future directions for deep venous arterialization, highlighting the ongoing need for research to advance limb preservation. --- TIMESTAMPS 00:00 - Introduction03:15 - The Inspiration Behind Their Podcast10:05 - Challenges and Success Stories in Vascular Surgery10:29 - Exploring Deep Venous Arterialization (DVA)25:16 - Hybrid Approaches and Patient Outcomes32:06 - Evolution of Endovascular Techniques37:33 - Patient Selection and Criteria38:52 - Understanding the Biology of Procedures43:57 - Exploring New Techniques and Devices58:52 - Challenges and Considerations01:01:51 - Final Thoughts --- RESOURCES Hybrid superficial venous arterialization and endovascular deep venous arterializationhttps://pubmed.ncbi.nlm.nih.gov/37404577/ Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemiahttps://www.nejm.org/doi/full/10.1056/NEJMoa2212754
Dr. Hoffman continues his conversation with Nathan Jones, CEO of Xlear, Inc.
Nathan Jones, CEO of Xlear, Inc., details the benefits of xylitol in dental and respiratory health products such as nasal sprays and chewing gums under the Spry brand. Nathan advocates for the FDA to allow anti-cavity claims for xylitol and other compounds despite the current monopoly of fluoride in such claims. They question the efficacy and potential downsides of fluoride, and explore alternative dental health interventions. The episode also covers xylitol's role in preventing tooth decay, respiratory health benefits during the COVID-19 pandemic, and ongoing legal challenges with the FTC. Discussions highlight the potential implications of oral health on systemic diseases like cardiovascular disease and Parkinson's, and emphasize the importance of nasal hygiene alongside dental care.
Whether you're looking for hope, practical advocacy tips, or updates on current legislation, you'll find inspiration in how collective action—powered by real stories—can fuel progress. Stay tuned for an uplifting, honest, and actionable conversation that's helping shape the future of women's health. This episode with Liz Powell, hosted by Lisa Malia covers timely topics like the FDA's recent announcement about hormone therapy, the vital work of the Breast Cancer Early Detection Coalition, and accessible ways anyone can join the movement for better health outcomes. TIMESTAMPS: 00:00 Women's Health Advocacy Network 05:28 Holistic Women's Health Advocacy 08:21 "Empowerment Through Advocacy Stories" 09:49 Hormone Therapy Misunderstood in WHI 15:43 Staying Hopeful Amid Overwhelm 17:09 "Easy Steps to Advocacy" 19:56 "Change Starts Within Us" 23:26 "2024: Women's Health Revolution" 28:49 Supplemental Breast Cancer Screening 30:30 "Fighting for Double Mastectomy" 36:19 Advocacy Secures Funding Success 39:52 "Open, Agile, Impactful Leadership" 41:26 "Grateful to Be Involved" LEARN MORE: The Clear Pathways Program: https://www.breastdensitysummit.org/ The Breast Density Summit: https://www.breastdensitysummit.org/webinar-registration MAKE A DONATION: https://www.paypal.com/donate?hosted_button_id=NJMF86A8Y9RJQ Follow LISA MALIA LinkedIn: https://www.linkedin.com/in/lisamalianorman/ WOMEN'S HEALTH ADVOCATES: https://womenshealthadvocates.org/ BREAST CANCER EARLY DETECTION COALITION: https://womenshealthadvocates.org/bcedc/ G2G CONSULTING: https://www.g2gconsulting.com Follow LIZ POWELL LinkedIn: https://www.linkedin.com/in/liz-powell-507b135/ Liz is Founder of G2G Consulting, which creates and implements government to growth (G2G) strategies for clients—securing $550 million since 2007. We advance health and high-tech innovation for businesses and nonprofits by accessing non-dilutive funding, shaping policies and regulations, and building relationships with key decision-makers. Liz founded the Women's Health Advocates, which is in all 50 states and has organized the first-ever Women's Health Capitol Hill Day on May 21, 2025, the Breast Cancer Early Detection Coalition Hill Day on July 16, 2025, Congressional Briefings and online forums, advocacy letter-writing campaigns, the drafting of legislative language, and grassroots mobilization events across the country. Previously, she served as Legislative Director in Congress where she staffed the Congressional Caucus for Women's Issues, Armed Services Committee and Small Business Committee and served as a Policy Analyst for UK Parliament's Health Committee as well as congressional and presidential political campaign staff. She has received the Woman Entrepreneur of the Year Award and Women of Achievement Award and earned her MPH from Harvard, JD from George Washington, and BA from Colgate.
This episode is full of counterfeit products and dupe talk, Glams! First, we make our plea for Miss Piggy to join us on the pod. We made our Wicked dreams come true, now we just need Miss “Moi” herself to join us. Then, we've partnered with the Personal Care Product Council to help keep you from buying fraudulent and potentially dangerous products this holiday season. We know it's easy to want a good deal, but there are some real red flags to look out for. For the headlines portion of the show, we discuss a new Bloomberg article about MCO Beauty, the Australian beauty brand that's made a name for itself by copying some of your favorite brands, from packaging design to inspired formulas. Kirbie changed her tune (kind of) after reading the story. And will we be getting better sunscreens in the U.S.? Possibly. We break down the FDA's update to sunscreen requirements. Watch our episodes!CALL or TEXT US: 424-341-0426Instagram: @glossangelspod, @kirbiejohnson, @saratanTwitter: @glossangelespod, @kirbiejohnson, @saratanEmail: glossangelespodcast@gmail.com Hosted on Acast. See acast.com/privacy for more information.
The brother of the man who died in ICE custody in Clearfield County in August has filed a lawsuit against the federal government. And a deep dive: Women going through menopause have a new option for treating symptoms like hot flashes and night sweats: An FDA approved, non-hormonal medication is now available.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.
Richard Pazdur took the top job at FDA's Center for Drug Evaluation and Research after receiving vows that he would be leading CDER free from political interference. On the latest BioCentury This Week podcast, BioCentury's analysts discuss the issues that could prove to be flashpoints between Pazdur and the heads of FDA and HHS, including personnel, RSV mAbs, puberty blockers and SSRIs.BioCentury's analysts assess bispecific innovation at the annual meeting of the Society for Immunotherapy of Cancer (SITC) and the growing field of companies pursuing RNAi, many of which have multiple unpartnered assets. Also featured in this week's episode: new funds from European VCs Medicxi and Sofinnova Partners, FDA's new plausible mechanism pathway and the Trump administration's “most favored nation” drug-pricing plan, which is turning out to be much more less onerous to drug companies than its original description suggested. This episode of the BioCentury This Week podcast is brought to you by Voyager Therapeutics.View full story: https://www.biocentury.com/article/657631#RNAiTherapeutics #BispecificAntibodies #CD3TCellEngagers #MechanismOfAction #ImmunoOncology #PlausibleMechanismPathway #RegulatoryScience #ClinicalTranslation00:01 - Sponsor Message: Voyager Therapeutics 03:08 - FDA's Richard Pazdur13:08 - Plausible Mechanism Pathway19:30 - Most Favored Nation23:12 - Takeaways from SITC28:05 - RNAi in China33:21 - European VCsTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text
An Evaluation of the FDA's Proposed Removal of Fluoride Prescription Drugs from the MarketBy Spring Hatfield, RDH, BSPHOriginal article published on Today's RDH: https://www.todaysrdh.com/an-evaluation-of-the-fdas-proposed-removal-of-fluoride-prescription-drugs-from-the-market/Need CE? Start earning CE credits today at https://rdh.tv/ce Get daily dental hygiene articles at https://www.todaysrdh.com Follow Today's RDH on Facebook: https://www.facebook.com/TodaysRDH/Follow Kara RDH on Facebook: https://www.facebook.com/DentalHygieneKaraRDH/Follow Kara RDH on Instagram: https://www.instagram.com/kara_rdh/
In this episode of The Dr. Terri Show, Dr. Terri sits down with her husband Dan DeNeui, CEO of Evexias Health Solutions, to unpack a healthcare scandal that's affected millions—and the movement that's about to change everything. Dan reveals the truth behind the FDA's recent removal of the black box warning on hormone replacement therapy, exposing how twenty years of misinterpreted data needlessly prevented women from accessing life-changing, disease-preventing treatments. Together, they pull back the curtain on what's really happening in Washington DC with the Make America Healthy Again (MAHA) initiative, sharing exclusive insights from high-level regulatory meetings and a recent healthcare innovation summit. They discuss the fight for medical freedom, why the current insurance system keeps you sick instead of healthy, how to find integrative medicine practitioners who focus on prevention over pills, and practical steps you can take right now to reclaim control of your health—even when insurance won't cover it. If you're ready to stop being a passive participant in a broken healthcare system and want to understand the once-in-a-generation opportunity we have to transform medicine for our kids and grandkids, this episode will leave you informed, empowered, and ready to take action. -- The Dr. Terri Show is presented by Evexias Health Solutions. For more, visit: https://www.evexias.com -- Connect with Dr. Terri DeNeui, DNP:
To kick off Food Safety Awareness Month, I'll be joined by Chef Keith Norman—ServSafe Instructor, Allergen Awareness Trainer, and Food Safety Manager/Assistant Executive Chef at South Point Hotel, Casino & Spa—on Eating at a Meeting Podcast LIVE. Keith lives and breathes safe dining, from the back-of-house kitchen line to the banquet floor where thousands of guests are served every day. And right now, food safety is in the headlines.
Send us an inquiry through a text message here!Welcome to another episode of The Veterinary Roundtable! In this episode, the ladies discuss the FDA issuing emergency use authorization for a drug that can combat screwworm, California banning cat declaws, the difference between a DVM and BVM degree, if hormone replacements for neutered dogs are real (WHAT?!) and more!Do you have a question, story, or inquiry for The Veterinary Roundtable? Send us a text from the link above, ask us on any social media platform, or email theveterinaryroundtable@gmail.com!Episodes of The Veterinary Roundtable are on all podcast services along with video form on YouTube!Timestamps00:39 - Intro03:04 - Pits and Peaks13:55 - Trending Vet Med Topics26:16 - Tales from the Trenches30:40 - Case Collections38:37 - Listener Inquiries53:50 - Outro
In this week's Digital Health Roundup, Medtech Insight's Marion Webb highlights her interviews with leaders at brain-computer interface developers Synchron and INBRAIN about funding, clinical trials and partnerships. Brian Bossetta discusses Oura's goal to secure US FDA clearance for a blood pressure feature for its smart ring. Elizabeth Orr highlights an FDA expert panel considering regulation of generative AI tools for mental health and Shubham Singh shines a light on Choice's efforts to develop a new form of contraceptive for women.
A bipartisan group of lawmakers is moving to curb the flood of illicit Chinese vapes entering the U.S. The END Act would expand the FDA's authority to destroy illegal products before they reach consumers. Learn more about your ad choices. Visit megaphone.fm/adchoices
The U.S. Food and Drug Administration announced last week that it would remove the “black box” warning labels on hormone therapy for menopause.These labels, which show up on medication packaging, warn of the risks of heart attack, breast cancer, stroke and blood clots. But the FDA now says these risks are based on outdated science.Tuesday on Midday Edition, we hear what this could mean for menopause treatment going forward, and what to know about hormone therapy more broadly.Guest:Dr. Kathryn Macaulay, clinical professor, OB-GYN, director of UC San Diego Menopause Health programResources mentioned:The Menopause Society
Subscribe to our channel: / @optispan Get Our Newsletter (It's Free): https://www.optispan.life/Join me for a fascinating conversation with Dr. Jamie Justice, Executive Director of the $101 Million XPRIZE Healthspan. In this podcast, we discuss the world of longevity science, from the ambitious goals of this global competition to the lessons learned from the stalled TAME trial.Dr. Justice explains how the XPRIZE is structured to find real-world solutions to extend human healthspan.Chapters:00:01:31 - Jamie's Role & The Mission of XPRIZE Healthspan00:02:29 - What is the XPRIZE Foundation?00:05:36 - The Genesis of the Healthspan Prize00:09:39 - Why Commercial Success Matters for the Prize00:10:51 - How to Win: The Competition Structure & Timeline00:18:50 - The 3 Key Healthspan Pillars: Cognitive, Physical, and Immune Function00:22:03 - Clinical Trial Design: Crossover Trials & "Responder" Analysis00:27:12 - The Types of Teams & Interventions (From Gene Therapy to Public Health)00:32:06 - Handling "Wild West" Clinics & The Importance of Data Transparency00:35:02 - How Many Teams Will Make it to the Finals?00:37:41 - Safety, Ethics, and Regulatory Hurdles00:43:42 - The FDA's Role and the Challenge of Approving "Aging" Interventions00:51:18 - The Story of the TAME Trial: Goals, Design, and Why It Stalled00:58:23 - The Real Reasons TAME Wasn't Funded (NIH Peer Review & More)01:07:09 - The Future of Large-Scale Aging Trials01:13:25 - The Good, The Bad, and The "Pheromones": Crazy XPRIZE Submissions01:16:49 - Breakdown of Finalist Categories: Drugs, Biologics, Supplements, and Multimodal Approaches01:22:20 - A Companion Prize for Biomarker Discovery01:27:30 - The Problem with "Biological Age" and Epigenetic Clocks01:31:44 - The Ethics of Using Direct-to-Consumer Age Tests in ClinicsAbout XPRIZE:XPRIZE's mission is to inspire and empower humanity to achieve breakthroughs that accelerate an equitable, abundant future.Website: https://www.xprize.org/Get Involved: https://www.xprize.org/get-involvedLinkedIn: / x-prize-foundation YouTube: / xprize X: http://x.com/xprizeInstagram: / xprize TikTok: / xprize Facebook: / xprize This video was produced by One Billion Media, an agency that specializes in YouTube virality for health brands and experts. Learn more about their work here:https://onebillionmedia.com/DISCLAIMER: The information provided on the Optispan podcast is intended solely for general educational purposes and is not meant to be, nor should it be construed as, personalized medical advice. No doctor-patient relationship is established by your use of this channel. The information and materials presented are for informational purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. We strongly advise that you consult with a licensed healthcare professional for all matters concerning your health, especially before undertaking any changes based on content provided by this channel. The hosts and guests on this channel are not liable for any direct, indirect, or other damages or adverse effects that may arise from the application of the information discussed. Medical knowledge is constantly evolving; therefore, the information provided should be verified against current medical standards and practices.More places to find us:Twitter: https://x.com/Optispan_IncTwitter: https://x.com/mkaeberlein Linkedin: / optispan Instagram: / optispan_ TikTok: / optispan https://www.optispan.life/Discover how teams worldwide are competing to prove they can reverse human aging by 10+ years, and why the winner might not be a drug at all.
BrainStorm wants to hear from you! Send us a text.The quest to speed up clinical trials is personal for John Dwyer, CEO of the Global Alzheimer's Platform (GAP). A long-time UsA2 advocate, he's been motivated by the generations of family members lost to Alzheimer's and Parkinson's disease. Dwyer shares with BrainStorm host Meryl Comer the critical challenges of NIH funding cuts by the Trump Administration, forcing many trial sites to shut down at a time of new FDA-cleared blood tests for early diagnosis. Dwyer highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities. This must listen episode reinforces clinical trial participation as a valuable care option while advancing research for millions affected by Alzheimer's and related dementias. This episode of BrainStorm is sponsored by Johnson & JohnsonSupport the show
Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a host of transformative events reshaping the landscape, from strategic acquisitions and funding infusions to regulatory maneuvers and scientific breakthroughs.Johnson & Johnson has taken a decisive step in its oncology strategy with the $3 billion acquisition of Halda's cell death technology. This acquisition, focusing on the "hold and kill" bifunctional small molecule platform, is poised to enhance J&J's prostate cancer pipeline significantly. It underscores J&J's commitment to expanding its oncology portfolio through innovative platforms designed to improve therapeutic outcomes. The move highlights a broader industry trend toward personalized medicine and targeted cancer therapies, which are becoming pivotal in improving patient care.In another domain of cancer treatment, Nuvalent has unveiled promising Phase 1/2 data for its candidate neladalkib, which could position the company as a formidable competitor to Pfizer's established lung cancer drug, Lorbrena. The promising data might expedite regulatory discussions with the FDA, potentially leading to an accelerated approval process. This development illustrates the competitive landscape in oncology, where firms strive to introduce novel therapies with improved efficacy and safety profiles.The field of antibody-drug conjugates (ADCs) is also experiencing significant advancements. A San Diego-based biotech has secured $120 million in funding to develop a best-in-class ADC formula, with support from Merck & Co. This initiative aims to refine the precision and efficacy of ADCs by delivering cytotoxic agents directly to cancer cells while minimizing collateral damage to healthy tissues. Such innovations are crucial as they represent a new frontier in targeted cancer therapy.In terms of financial activities, Artios Pharma's successful $115 million Series D funding round is set to bolster its clinical efforts in exploring DNA damage response inhibitors for cancer treatment. These inhibitors target cancer cells' ability to repair DNA damage, holding potential for more effective therapies against resistant cancer types. Meanwhile, Sofinnova Partners' €650 million raise for biotech and medtech investments amid a volatile economic environment underscores continued investor confidence in life sciences despite market uncertainties.Bayer is making strategic moves in China by opening an incubator in Beijing. This facility will host local biopharma companies such as Suzhou Puhe Biopharma and Beijing Youngen Technology, fostering innovation and collaboration within China's burgeoning biotech landscape. Such initiatives reflect global efforts to leverage regional strengths and foster cross-border collaborations.On the operational side, Nxera Pharma is restructuring its workforce by laying off 15% of its staff as part of a strategic pivot towards profitability. This decision mirrors broader industry trends where companies refocus resources on core projects to streamline operations and enhance financial stability.A recent study has highlighted the impact of NIH grant cuts on clinical trials across the United States. Over 383 trials involving more than 74,000 patients have been disrupted due to funding terminations under the current administration. This situation raises concerns about the sustainability of clinical research funding and its implications for ongoing medical advancements.Jazz Pharmaceuticals has reported practice-changing Phase 3 results for its HER2-targeted drug Ziihera for gastroesophageal adenocarcinoma. These findings reaffirm Jazz's confidence in positioning Ziihera as a preferred first-line treatment option for HER2-positive cancers, poSupport the show
We often separate kindness from science, but they are deeply connected at a cellular level. Mark Young reveals how the act of giving actually triggers physiological changes that clear cognition, reduce stress, and might be the key to your next breakthrough.In this episode, Mark explains the powerful childhood story that led to his book, Radical Generosity, and why solving someone else's problem is the ultimate hack for your own nervous system. We also get into the weeds of his company, Zona Health. He details the fascinating science of how a simple isometric hand grip exercise signals the body to release nitric oxide and potassium, which rehydrates the endothelial lining and improves cardiovascular flexibility.“You will be healthier if you figure out what you can eliminate rather than what you can add.” - Mark YoungSupport the show and get 50% off MCT oil with free shipping—just leave us a review on iTunes and let us know!https://podcasts.apple.com/us/podcast/live-beyond-the-norms/id1714886566 Mentioned in this Episode:- Book: Radical Generosity (Mark Young): https://a.co/d/i4QpjEP - Device: Zona Plus isometric handgrip biofeedback: https://www.zona.com/ - Book: Trillion Dollar Coach: https://a.co/d/8Q3No4g About Mark Young:Mark Young is a Mensa member, CEO of Ryze Agency, and CEO of Zona Health. With degrees spanning psychology, theology, functional medicine, and business administration, he helps health and wellness entrepreneurs elevate their brands through science-backed storytelling. His book, Radical Generosity, explores how giving unlocks breakthroughs in business, relationships, and personal transformation. Through Zona Health, Mark is bringing FDA clinical trials to a biofeedback device that uses isometric exercise to naturally reduce blood pressure and restore cardiovascular flexibility.Connect with Mark Young:- Website: https://themarkyoung.com - Instagram: https://www.instagram.com/themarkyoung/ - YouTube: https://www.youtube.com/@performancedrivenlivingpodcast - Zona Health: https://zona.com Use code CHRIS100 for $100 off on the Zona Health device.Connect with Chris Burres:- Website: https://www.myvitalc.com/ - Website: http://www.livebeyondthenorms.com/ - Instagram: https://www.instagram.com/chrisburres/ - TikTok: https://www.tiktok.com/@myvitalc - LinkedIn: https://www.linkedin.com/in/chrisburres/
Welcome to RIMScast. Your host is Justin Smulison, Business Content Manager at RIMS, the Risk and Insurance Management Society. In this episode, Justin interviews Julia Anna Potts, President and CEO of the Meat Institute, about her career, background, lifelong interest in agriculture and food, and how she joined the Meat Institute following a career in environmental law. The discussion covers the role of the Meat Institute in the food supply chain and how it serves member companies and the food industry in general, through its food safety best practices and a free online course, "The Foundations of Listeria Control." Julia reveals the Protein PACT initiative and explains how food safety relates to risk management with their shared values. She tells how meat processors are good community members. Listen for advice on the culture of safety and how it starts at the very top of the organization. Key Takeaways: [:01] About RIMS and RIMScast. [:17] About this episode of RIMScast. We will be joined by Julia Anna Potts, the CEO of the Meat Institute. We'll discuss food safety and education, and risk frameworks that the Institute uses to ensure that our food and supply chains are clean. But first… [:47] The next RIMS-CRMP-FED Exam Prep with AFERM will be held on December 3rd and 4th. The next RIMS-CRMP Exam Prep with PARIMA will be held on December 4th and 5th. These are virtual courses. [1:03] Links to these courses can be found through the Certifications page of RIMS.org and through this episode's show notes. [1:11] RIMS Virtual Workshops! On November 19th and 20th, Ken Baker will lead the two-day course, "Applying and Integrating ERM." [1:24] "Managing Data for ERM" will be led again by Pat Saporito. That session will start on December 11th. Registration closes on December 10th. RIMS members always enjoy deep discounts on the virtual workshops. [1:40] The full schedule of virtual workshops can be found on the RIMS.org/education and RIMS.org/education/online-learning pages. A link is also in this episode's notes. [1:52] This episode is released on November 18th, 2025, Day Two of the RIMS ERM Conference in Seattle, Washington. We've covered a lot of ERM ground in the last few episodes. For more ERM, click the link to the RIMS ERM Special Edition of Risk Management magazine in the notes. [2:18] RIMScast ERM coverage is linked as well. Enhance your ERM knowledge with RIMS! [2:24] On with the show! Our guest is Julie Anna Potts. She is the President and CEO of the Meat Institute. She leads the Institute in implementing programs and activities for the association. [2:38] She is an agricultural veteran, previously serving the American Farm Bureau Federation as its Executive Vice President. [2:47] With Thanksgiving coming up next week in the U.S., I thought this would be a great time on RIMScast to talk about food safety, food production, and what another not-for-profit is doing to ensure the safety of our products and the speed and efficiency of our supply chain. [3:07] We're going to have a lot of fun and talk turkey, so let's get to it! [3:12] Interview! Julie Anna Potts, welcome to RIMScast! [3:27] Julie Anna Potts and RIMS CEO, Gary LaBranche, are both part of the Committee of 100 with the U.S. Chamber of Commerce in Washington, D.C. They get together with other association heads across industries. Julie Anna says it is very valuable. [3:44] Julie Anna and Gary were talking in the summer about food safety and about what the Meat Institute does, and Gary invited her to be on RIMScast. [3:57] Justin notes that it is the week before Thanksgiving in the U.S. Juliana says they are doing so much in Washington now, and food safety is always top-of-mind around the holidays. There are lots of turkeys and turkey products being sold in the United States. [4:45] Julie Anna says turkey is cultural for Thanksgiving, and poultry, and how you cook it and handle it in the kitchen is incredibly important for food safety. [5:01] Justin asks, Is fish meat? Julianna says fish is protein, but we don't classify it as meat or poultry. Justin wants to keep the argument going with his family at Thanksgiving. [5:31] Julie Anna says they have lots of arguments around the Meat Institute, like whether ketchup belongs on hot dogs. Julie Anna says the answer to that is no. [5:41] Julie Anna has been at the Meat Institute for a little over seven years. She came in as President and CEO. She has been in Washington for most of her career, since undergrad. She graduated from law school in D.C. and worked at a firm. [5:59] Julie Anna has been in agriculture, representing farmers for years. She went to the Senate as Chief Counsel of the Senate Agriculture Committee. She has been at the Meat Institute for the last seven years. [6:19] Food and agriculture have been central to Julie Anna's career and also to her family life. Her husband grew up on a farm. Julie Anna is two generations off the farm. [6:32] They love to cook, dine out, and eat with their children; all the things you do around the holidays, and gather around the Thanksgiving table. They have passed to one of their three children their love of food traditions. She's their little foodie. [6:52] Julie Anna has a career and a personal life that is centered around food. [7:11] The Meat Institute members are the companies that slaughter animals and do further processing of meat. They are in the supply chain between livestock producers and retail and food service customers. [7:35] To be a general member of the Meat Institute, you have to have a Grant of Inspection from the Food Safety Inspection Service of the USDA. The Federal Grant of Inspection is a requirement to be able to operate and to sell into the market. [7:56] When we look at the capacity we have at the USDA, in the last several months, we're not seeing a decline in capacity, but more emphasis on our Food Safety Inspection Service. [8:18] Through DOGE, voluntary retirements, through additional resources coming in with the One Big Beautiful Bill, and through recruiting, the Meat Institute is seeing its member companies have staffing, even through this government shutdown. They're considered essential, as always. [8:54] The Meat Institute was established in 1906 for the purpose of addressing food safety and industry issues. Those are Jobs One, Two, and Three, every day. The Meat Institute has all kinds of education it offers to its members. [9:15] The members of the Meat Institute have strong food safety programs. They have HASSA Plans and third-party audits. The Meat Institute helps any member company of any size, from 25 employees to global companies, with education on, for example, Listeria training. [9:53] The Meat Institute has just launched an online platform that has had great uptake. If you have associates in your business who have never had food safety training, for all levels of folks, there is online, free, and freely available training on how to deal with Listeria. [10:19] All the Meat Institute member companies have significant Food Safety staffing and Food Safety Quality Assurance Programs. Julie Anna praises the people throughout the industry who work in Food Safety for their companies. It's a life-or-death matter. [10:45] Food Safety staff are always seeking to become better, so the Meat Institute has a Food Safety Conference and Advanced Listeria Training (an in-person module). They interface with the regulators, who are partners with the Meat Institute in this. [11:14] The Meat Institute is always striving for better Best Management Practices across everyone's programs, which are never just the minimum. A philosophy of doing just what is compliant does not get you into the best space. [11:36] The Meat Institute is here to encourage Best in Class, always. Food Safety is non-competitive in the Meat Institute. Everyone across the different-sized companies, from 25 employees to 100,000, can feel comfortable sharing what's working for them. [12:06] That is important when it comes to conferences and other things they do. Let's be candid with each other, because nobody can get better if you're not. [12:17] The Meat Institute has seen cultural issues where CEOs don't think about Food Safety and Quality Assurance because they have great people taking care of it. That's true a lot of the time, until it isn't. [12:42] The tone that needs to be set at the very top of the organization is that this is hugely important for risk management. Hugely important for your brand and your ability to operate. [12:56] The Meat Institute board asked, if we are pushing culture down through the organization, what kinds of questions do I need to ask, not just my Food Safety Team, but everyone, and demonstrating my knowledge, understanding, and commitment to governance of this big risk? [13:31] The Meat Institute created a template of a set of questionnaires for executives. It is a C-Suite document and documentation. [13:47] It's a voluntary questionnaire for a CEO, regardless of company size, indicating that you understand how important this is in ensuring that everything that you push down through your organization, culturally, is focused on Food Safety. [14:05] The link to the Listeria Safety Platform is in this episode's show notes. [14:11] Justin says the structure of the Meat Institute is very similar to the structure of RIMS, with open communications and knowledge-sharing, or else the industry does not grow or improve. [14:27] Justin says it sounds like the industry executives are stepping up their game amid the tumult coming out of Washington. Julie Anna agrees. [14:47] Julie Anna says the Meat Institute has been driving that progress. It is incredibly important. Julie Anna thinks that in a lot of industries, there is a pull and tug between the companies and regulators. [15:07] In the case of meat and poultry inspection and what the Meat Institute does with FSIS, it is a collaboration. The inspectors verify for consumers what the companies are doing to keep food safe. [15:28] It is up to the company to decide how it is going to do this effectively and successfully and get better at it. [15:41] Numerous third parties do audits and help customers across the supply chain, but the responsibility rests with the companies. [15:59] The Meat Institute staff has highly technical people who come out of academia, out of the plant, having done FSQA, Legal, and safety regulations. There are folks who have been in inspection in the government at FSIS. [16:29] The Meat Institute has several staff whose job it is to stay on top of the latest improvements and ensure that everybody knows what those are, and in dialogue with our FSIS inspection leadership here in Washington, D.C. [16:46] The Meat Institute looks to FSIS to make sure that consumer confidence is there. It does nothing for our industry if consumers think that FSIS isn't being an effective regulator. [17:11] The Meat Institute companies have to be the ones that do more than the bare minimum to ensure they're doing the best they can. The Meat Institute's philosophy is always to push further and further. [17:25] There is an expense associated with that. The Meat Institute does its best to help manage that risk for its companies by giving them everything they need to be the best that they can be. [17:40] The Meat Institute has 36 employees. They are very transparent in the Food Safety world. They want non-members to take advantage of all their resources in Food Safety. A lot of the things they offer on education and regulations can be accessed without being a member. [18:14] The Meat Institute has recently joined an alliance to stop food-borne illness and is looking to get more engaged in that organization. That's across several segments, not just meat and poultry. [18:35] The Meat Institute has committed and re-committed over the years to the efforts it makes with its companies. The Meat Institute looks for its companies to be leaders in the Food Safety space. [18:53] Quick Break! The RIMS CRO Certificate Program in Advanced Enterprise Risk Management is our live virtual program led by the famous James Lam. Great news! A third cohort has been announced, from January through March 2026! [19:14] Registration closes January 5th. Enroll now. A link is in this episode's show notes. [19:22] Save the dates March 18th and 19th, 2026, for The RIMS Legislative Summit, which will be held in Washington, D.C. [19:31] Join us in Washington, D.C., for two days of Congressional Meetings, networking, and advocating on behalf of the risk management community. Visit RIMS.org/Advocacy for more information and updates and to register. [19:45] We've got more plugs later. Let's return to our interview with Meat Institute CEO Julie Anna Potts! [19:56] Julie Anna says a lot of our companies are also regulated by the FDA because they do further processing. For example, pizzas with pepperoni, or any number of mixed products that have both FDA and USDA regulatory personnel on site. [20:20] FSIS is, by far, more present and more in tune with what member companies are doing than the inspectors at the FDA. [20:30] Justin asks if restaurants can be members of the Meat Institute. There is a segment of membership called Allied Members, which includes restaurants and grocery stores. If they are not processors, but they are procuring meat and poultry for sale, they are in the meat industry. [21:09] The Meat Institute has had a great deal of interaction on many issues with its retail and food service customers. [21:25] Shortly after she joined the Meat Institute, Julie Anna was handed a mandate from the board to be proactive and lean in on the things consumers are interested in with an initiative to continue to maintain or rebuild trust. [21:48] These are things like food safety, animal welfare, environmental impact, and worker safety. They call this initiative Protein PACT (People, Animals, and the Climate of Tomorrow). Food Safety is front and center in Protein PACT. [22:13] The Meat Institute has a way of focusing its efforts through this lens of improvement in five areas that work together to reassure consumers. When they know that you're working on all these issues and trying to improve, it increases trust in all the above issues. [22:54] Retail and Food Service customers in the industry want to know more and more. They want to know upstream, what are you doing to get better? [23:05] They want to know how they can take the data that you are collecting anonymously and in the aggregate to communicate at the point-of-sale area to ensure that their customers, collectively, are getting what they need? [23:23] Julie Anna saw this recently at H-E-B, a popular grocer in Texas. Julie Anna walked through one of their huge, beautiful, newly renovated stores. The engagement the ultimate customer has is in the store, asking questions of the butcher. [24:07] It's wonderful to be able to say, If you have food safety concerns, we have a relationship that we can give you the knowledge you need to answer those concerns, and it's coming very consistently across the industry. [24:40] Justin asks, When the Meat Institute members lean in, are they leaning in at 85% or 93%? You'll only get ground beef jokes here, on RIMScast! Julie Anna says, it's all good. Justin says those kinds of jokes are called The Manager's Special. [25:17] One Final Break! RISKWORLD 2026 will be held from May 3rd through the 6th in Philadelphia, Pennsylvania. RISKWORLD attracts more than 10,000 risk professionals from across the globe. Guess what! Booth sales are open now! [25:37] This is the chance to showcase your solutions, meet decision-makers face-to-face, and expand your global network. Connect, Cultivate, and Collaborate with us at the largest risk management event of the year. The link to booth sales is in this episode's show notes. [25:53] Let's Return to the Conclusion of My Interview with Meat Institute CEO Julie Anna Potts! [26:16] Julie Anna was an environmental lawyer in private practice. Her work involved the Clean Water Act, the Clean Air Act, the National Environmental Policy Act, and Superfund. One of her clients was the American Farm Bureau Federation (AFBF). [26:42] When Julie Anna left the firm, she moved in as General Counsel to the AFBF, the largest general farm organization in the U.S. Besides environmental law, she worked there in lots of other types of law as General Counsel. [27:06] At the Meat Institute, Julie Anna collaborates with the AFBF. The ag sector in Washington, D.C., is very collaborative. The Meat Institute works closely with the National Cattlemen's Beef Association, the National Pork Producers Council, and the commodity groups. [27:35] Everybody is connected. If you are working on an animal issue, you're going into crop groups and animal health companies. The Meat Institute works with everyone. Their philosophy is, We all get better when we share knowledge. [28:03] That's the basis of the conversation Julie Anna and Gary LaBranche had in the summer about this podcast. The Meat Institute has resources it would love to share on the risk management of food safety issues. [28:20] The Meat Institute also knows consultants and other help outside of the meat industry that they can point people to, as needed. The Meat Institute would love to be a resource to the listeners of RIMScast. You can check out the contact information in the show notes. [29:02] Julie Anna is familiar with risk professionals. She serves on the board of Nationwide Insurance. Nationwide Agribusiness has Food Safety expertise. When Julie Anna practiced law, she worked with clients on helping them manage risk and assess potential outcomes. [30:09] Julie Anna says risk management is one of her favorite topics. How do you plan to recover from a flood after a hurricane? How do you plan for farm animal disease? There are now three animal disease outbreaks that are constantly on their minds at the Meat Institute. [30:31] The Meat Institute helps run tabletop exercises with its companies, sometimes involving government officials, as well. It's New World Screwworm to the South. It's High Path Avian Influenza, which has crossed over from poultry to dairy and beef cattle. [30:48] Julie Anna continues, We have African Swine Fever, which has not gotten to the United States, thank goodness! All of these require a certain level of preparedness. So we work on it as a policy matter, but we also need to operationalize what happens when this happens. [31:16] The pandemic is a good recent example of what happens when things fall apart. Member companies have a very limited ability to hold live animals if they're not going to slaughter. They don't have anywhere to go. [31:44] The pandemic was an example of what happens when something reduces capacity and the animals start backing up. It's incredibly important that things work. The pandemic was unimaginable to a lot of people. It tested our risk management models. [32:10] Once we were there, dealing with it, we had incredible adaptability to the circumstances we were facing. That only happens if you face certain problems every day to keep that plant running. For member companies, if the plants don't run, the animals don't have a place to go. [32:37] Farmers get a lower price for their animals, consumers have the perception that there's not going to be enough food, and there's a run on the grocery stores. During the pandemic, it righted itself really quickly, once we got some PPE, etc. in place, and some guidance. [32:59] The member companies relied heavily on the CDC to tell them how to get people in so the plants could run. It was difficult for everyone. Julie Anna thinks that we learned a lot from that experience on how to help your company troubleshoot in the moment to keep going. [33:37] Julie Anna addresses how PFAS issues are being handled. It's an EPA issue and a state's issue for regulations on packaging and recycling. The state issues are predominant. Environmental issues are being addressed at the state level. We could end with 50 regimes. [35:04] That's where there's more risk for the Meat Institute and its members, especially companies that sell nationwide. There is very little state regulatory work that the Meat Institute does directly. [35:26] The Meat Institute is examining how to utilize other resources to figure out, with a small staff, how to monitor and stay ahead of these things for our members. That's very much on their minds. The EPA's work has been swinging back and forth between administrations. [36:02] It's hard to convince a business of a good recommendation if the rules are going to change with the next administration. It's a problem of where to invest in things like measuring emissions and what to do to satisfy customers when the rhetoric changes dramatically. [37:04] Justin says we've had a different administration every four years for the last 16 years. He says if he were a business owner, he would do everything he could to make sure the water coming in and going out is clean to avoid verdicts. Nuclear verdicts are through the roof. [37:27] Julie Anna speaks of social inflation by juries wishing to send a message to big corporate entities. She says member companies are dealing with these issues all the time. What's the right amount of rulemaking for effluent limitation guidelines? [38:20] The Meat Institute had opposed what the Biden administration had proposed, given that the number of companies it estimated would not be able to stay in business was close to 80. The Trump administration has backed off and is leaving in place what was there before. [38:52] That's all part of the Federal policy debate in D.C. It does not diminish the commitment its members have to be good community members. They work in their communities. Julie Anna was just down in East Tennessee at a wonderful family company, Swaggerty Sausage. [39:16] They do water treatment. They are beloved in the community because of how they take care of people. They bring in pigs from North Carolina and turn them into sausage. Julie Anna met the fifth generation. He is eight months old. [39:40] Julie Anna had a great visit with people, understanding how their commitment to the environment and animal welfare, and the things they can show their community members that they are doing, works for them. Julie Anna saw how the sausage is made, Justin adds. [40:28] Justin says, You've been such a delight to speak with, and we've learned so much. Is this the busiest time of year for your members, with Thanksgiving coming up, the religious holidays coming up, and then New Year's? Are they keeping Safety at the top of their risk radar now? [40:59] Julie Anna says Our members, and we, keep Safety at the top of the risk radar every single day. It does not get harder during high-volume days. [41:15] There's a spike around Memorial Day, Fourth of July, and Labor Day. There's a lot more turkey happening around Thanksgiving and possibly Christmas, but certainly, hot dogs, hamburgers, sausages, brisket, and all kinds of things. It's cyclical. [41:49] Julie Anna wishes Justin could come into a plant with her, walk through, and see the number of times there are interventions for food safety. X-rays for foreign material. Sprays for certain types of pathogens, and the ways in which the hide is treated. [42:14] It is such a huge part, and they are so proud of what they do. They are happy to show anybody how we continue to hold that up as the most important thing. Worker Safety is also hugely important. We're talking about our humans and what we do to protect them. [42:42] Safety is really important, and it does not receive any less attention at busy times. [42:50] Justin says that's a great sentiment to close on. It has been such a delight to speak with you, and I'm so glad we had the chance to do this. It's going to be especially impactful now, just ahead of Thanksgiving and the religious holidays, and the New Year. [43:16] Special thanks to Julie Anna Potts of the Meat Institute for joining us here on RIMScast just ahead of Thanksgiving 2025. Links to the Meat Institute resources are in this episode's show notes, as is RIMS coverage of Food Safety and related topics. [43:34] Plug Time! You can sponsor a RIMScast episode for this, our weekly show, or a dedicated episode. Links to sponsored episodes are in the show notes. [44:02] RIMScast has a global audience of risk and insurance professionals, legal professionals, students, business leaders, C-Suite executives, and more. Let's collaborate and help you reach them! Contact pd@rims.org for more information. [44:20] Become a RIMS member and get access to the tools, thought leadership, and network you need to succeed. Visit RIMS.org/membership or email membershipdept@RIMS.org for more information. [44:38] Risk Knowledge is the RIMS searchable content library that provides relevant information for today's risk professionals. Materials include RIMS executive reports, survey findings, contributed articles, industry research, benchmarking data, and more. [44:54] For the best reporting on the profession of risk management, read Risk Management Magazine at RMMagazine.com. It is written and published by the best minds in risk management. [45:09] Justin Smulison is the Business Content Manager at RIMS. Please remember to subscribe to RIMScast on your favorite podcasting app. You can email us at Content@RIMS.org. [45:21] Practice good risk management, stay safe, and thank you again for your continuous support! Links: RIMS-CRO Certificate Program In Advanced Enterprise Risk Management | Jan‒March 2026 Cohort | Led by James Lam RISK PAC | RIMS Advocacy | RIMS Legislative Summit SAVE THE DATE — March 18‒19, 2026 RIMS-Certified Risk Management Professional (RIMS-CRMP) Reserve your booth at RISKWORLD 2026! The Strategic and Enterprise Risk Center RIMS Diversity Equity Inclusion Council RIMS Risk Management magazine | Contribute RIMS Risk Management Magazine: "USDA Budget Cuts Present Food Safety Risks" (May 2025) Meat Institute Meat Institute — Foundations of Listeria Control RIMS Risk Management magazine ERM Special Edition 2025 RIMS Now Upcoming RIMS Webinars: RIMS.org/Webinars Upcoming RIMS-CRMP Prep Virtual Workshops: RIMS-CRMP-FED Exam Prep with AFERM Virtual Workshop — December 3‒4 RIMS-CRMP Exam Prep with PARIMA — December 4‒5, 2025 Full RIMS-CRMP Prep Course Schedule "Applying and Integrating ERM" | Nov 19‒20, 2025 | April 4, 2026 "Leveraging Data and Analytics for Continuous Risk Management (Part I)" | Dec 4. See the full calendar of RIMS Virtual Workshops RIMS-CRMP Prep Workshops Related RIMScast Episodes: "Recipes for Success with Wendy's CRO Bob Bowman" "Franchise Risks with Karen Agostinho of Five Guys Enterprises" "Risk Insight with AAIN Leadership and Panda Express" Sponsored RIMScast Episodes: Secondary Perils, Major Risks: The New Face of Weather-Related Challenges | Sponsored by AXA XL (New!) "The ART of Risk: Rethinking Risk Through Insight, Design, and Innovation" | Sponsored by Alliant "Mastering ERM: Leveraging Internal and External Risk Factors" | Sponsored by Diligent "Cyberrisk: Preparing Beyond 2025" | Sponsored by Alliant "The New Reality of Risk Engineering: From Code Compliance to Resilience" | Sponsored by AXA XL "Change Management: AI's Role in Loss Control and Property Insurance" | Sponsored by Global Risk Consultants, a TÜV SÜD Company "Demystifying Multinational Fronting Insurance Programs" | Sponsored by Zurich "Understanding Third-Party Litigation Funding" | Sponsored by Zurich "What Risk Managers Can Learn From School Shootings" | Sponsored by Merrill Herzog "Simplifying the Challenges of OSHA Recordkeeping" | Sponsored by Medcor "How Insurance Builds Resilience Against An Active Assailant Attack" | Sponsored by Merrill Herzog "Third-Party and Cyber Risk Management Tips" | Sponsored by Alliant RIMS Publications, Content, and Links: RIMS Membership — Whether you are a new member or need to transition, be a part of the global risk management community! RIMS Virtual Workshops On-Demand Webinars RIMS-Certified Risk Management Professional (RIMS-CRMP) RISK PAC | RIMS Advocacy RIMS Strategic & Enterprise Risk Center RIMS-CRMP Stories — Featuring RIMS President Kristen Peed! RIMS Events, Education, and Services: RIMS Risk Maturity Model® Sponsor RIMScast: Contact sales@rims.org or pd@rims.org for more information. Want to Learn More? Keep up with the podcast on RIMS.org, and listen on Spotify and Apple Podcasts. Have a question or suggestion? Email: Content@rims.org. Join the Conversation! Follow @RIMSorg on Facebook, Twitter, and LinkedIn. About our guest: Julie Anna Potts, CEO, The Meat Institute Production and engineering provided by Podfly.
Process innovation in the pharmaceutical industry is never easy, but its best chance of success comes when companies come together to work on big problems – especially when they bring in regulators and other stakeholders. In today's episode of the pharmaphorum podcast, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio management at TransCelerate Biopharma, a membership organisation where big pharma companies work together to innovate around the discovery, development, and manufacturing of new drugs. DiCicco gives an update on TransCelerate's work with pragmatic trials and the group's meetings last year with the FDA. He discusses what pragmatic trials are and how they can improve the efficiency of clinical research, as well as describing the work that was done at the meeting last year and the report that's come out of it. He also gets into next steps, how the new administration has and hasn't affected the work TransCelerate is doing with the FDA, and the role TransCelerate plays in taking these recommendation and putting them into practice. Tune in to learn how the pharma industry is working together to change the way clinical trials are done.
In this episode, we tackle one of the most common questions in pregnancy of late: Is Tylenol safe? It's the medication nearly every pregnant person reaches for at some point, yet the internet is full of conflicting headlines and confusing studies. We break down what the data actually shows, when Tylenol is appropriate, and how to use it safely. What We Cover • Why Tylenol (acetaminophen) is considered one of the first-lines in pregnancy We explain decades of clinical use, major guideline recommendations, and why it remains the preferred option for fever and pain relief. • What the research actually says about safety We unpack the difference between correlation and causation, discuss recent observational studies, and highlight what ACOG and SMFM currently recommend. • When Tylenol is truly needed Fever above 100.4, migraines, musculoskeletal pain, postpartum use, and how untreated fever or pain can create more risk than the medication itself. • How to use it safely Typical dosing, maximum limits in 24 hours, how to avoid hidden acetaminophen in combination products, and who should be more cautious. • What to avoid We clarify why NSAIDs (like ibuprofen) are not recommended in most stages of pregnancy and why people often confuse these medications. Resources Mentioned • ACOG guidance on pain and fever management during pregnancy • SMFM clinical recommendations • FDA medication safety overview (pregnancy and lactation) Call to Action If you have questions about medication safety in pregnancy or aren't sure what's right for your symptoms, talk with a clinician who understands the nuances of both maternal health and functional medicine. The right guidance can give you confidence and peace of mind. Got something you want to share or ask? Keep it coming. We love hearing from you. Email us or send a voice memo, and you might just hear it on the next episode. Don't forget to like, comment, and subscribe—your questions could be featured in our next episode! For additional resources and information, be sure to visit our website at Maternal Resources: https://www.maternalresources.org/. You can also connect with us on our social channels to stay up-to-date with the latest news, episodes, and community engagement: YouTube: Dive deeper into pregnancy tips and stories atyoutube.com/maternalresources . Instagram: Follow us for daily inspiration and updates at @maternalresources . Facebook: Join our community at facebook.com/IntegrativeOB Tiktok: NatureBack Doc on TikTok Grab Our Book! Check out The NatureBack Method for Birth—your guide to a empowered pregnancy and delivery. Shop now at naturebackbook.myshopify.com .
The FDA belatedly liberates women's hormone replacement; Beta-blockers now deemed passé for routine heart attack aftercare; After most breast cancer surgery, adjuvant radiation brings no survival benefits; Can you drink caffeinated coffee if you have atrial fibrillation? Ignore frequent falls without attention to balance and stability training at your peril; Is it reasonable to contemplate a knee replacement surgery at 88?
The best biotech and pharmaceutical innovations mean nothing if they can't be protected—and protected fast. Our next guest, Josh Goldberg, is solving this challenge as co-managing partner at Nath, Goldberg & Meyer, the #1 ranked patent law firm for biotech and pharmaceutical technologies. With nearly three decades of IP law experience and a unique background as a lab researcher, Josh brings an insider's understanding of how innovation actually happens. He's helped industry leaders like Amgen, Takeda, and GlaxoSmithKline turn breakthrough treatments into patent-protected portfolios—often in under a year instead of the typical four-year timeline. Driven by a passion for focus and strategic IP timing, Josh shares his pioneering approach to biotech and pharmaceutical patent prosecution. Join us to discover how smart IP strategy drives licensing power, regulatory success, and company valuation. Let's go!Episode Highlights:Focus drives success – Companies fail by trying to do everything at once; staying deliberate and focused is key to making real impactOne-year patent timelines vs. four years – Josh uses USPTO's Track 1 program to secure patents in record time, improving fundraising and M&A positioningClient-centered approach wins – Listening to unique client needs instead of one-size-fits-all strategies earned the firm its #1 rankingDiagnostic patents are back – New USPTO Director signals the patent office is "open for business" again after a decade of restrictionsScientist turned patent attorney – Josh's lab background gives him insider understanding of how innovation actually happensAbout our Guest: Joshua is the patent attorney innovation-driven pharmaceutical companies call when they need to turn complicated technologies into protected assets in record time.As co-managing partner at Nath, Goldberg & Meyer—the #1 ranked patent law firm for biotech and pharmaceutical technologies in both 2024 and 2025—Joshua leads IP efforts across industries like biotech, pharma, agriculture, renewable energy, and advanced materials. Whether it's a blockbuster acne treatment like DUAC, a vitamin D analog lotion like Sorilux, OTC solutions like Salonpas and Germagic, or a leading drug used to reduce stomach acid and treat conditions like GERD, ulcers, and heartburn—like Protonix—Joshua helps turn high-stakes R&D into patent-protected portfolios, often in under a year instead of the typical four-year timeline.Though his climate and agricultre IP expertise has made him famous as the “green patent guy,” Joshua moves between disciplines skillfully and has helped industry leaders like Amgen, Takeda, Guilford Pharmaceuticals, Mayne, and Stiefel Laboratories (which was acquired by GlaxoSmithKline) build pharma portfolios that hold up under investor, acquirer, and FDA scrutiny.His journey didn't begin in IP law, but in the lab, researching experimental pharmaceutical delivery systems. It gave him an edge most attorneys don't have: understanding how innovation actually happens, and how to protect it without slowing a business down. Links Supporting This Episode: Nath, Goldberg & Meyer Website: CLICK HEREJoshua Goldberg LinkedIn page: CLICK HERENath, Goldberg & Meyer LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page:...
In this powerful episode of The MisFitNation, host Rich LaMonica welcomes Dr. Eugene Lipov — physician, researcher, and the world's leading expert on using Stellate Ganglion Block (SGB) to treat post-traumatic stress. Dr. Lipov pioneered the use of SGB for trauma recovery in 2006, adapting a decades-old FDA-approved procedure into a breakthrough therapy for PTSD. He later developed the Dual Sympathetic Reset (DSR) protocol, which has helped thousands experience rapid and life-changing relief. Motivated by his own family's experience with trauma, Dr. Lipov is also a global advocate for redefining PTSD as Post-Traumatic Stress Injury (PTSI) — a term that removes stigma and reflects the biological nature of the condition. His work has been featured in The Wall Street Journal, USA Today, Fox National News, NBC, and numerous medical journals. He has testified before Congress, worked with military organizations worldwide, and continues to push trauma treatment into a new era of science-backed innovation. Learn more at DrEugeneLipov.com http://thegodshotbook.com
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor dive into your burning questions from around the world—exploring misunderstood metabolic problems, hard-won solutions for real people, and the science behind the headlines. From “selfish brain” physiology to the rollercoaster of insurance and medication access, Dr. Cooper brings clinical clarity and practical hope.Hear real-world listener stories, get advice on tuning your metabolic health, and learn why personalization—not “calories in, calories out”—leads to better outcomes. This is no silver bullet show: it's metabolic medicine, mythbusting, and science-backed encouragement for your journey.Key Questions AnsweredWhat is the “selfish brain” and how does it really impact blood sugar and diabetes risk?Why do GLP-1 medications affect stamina and hunger, and how should you fuel your body if you're using them?If insurance pulls coverage for medications like Ozempic or Zepbound, what are your practical, safe, and affordable options?How do metabolic markers, medication “cocktails,” and genetic testing shape Dr. Cooper's individualized care—and can you taper off meds and maintain results?What does “normal” blood sugar look like after meals, and how do you distinguish trends from outliers?Key TakeawaysMetabolism is complex—individualized care is essential. Diabetes, hypoglycemia, and insulin resistance all have personal causes and require testing like the Mixed Meal Tolerance Test to solve—not one-size-fits-all advice. GLP-1s require smart fueling. Many experience reduced stamina on these medications. Dr. Cooper recommends upping both complex and simple carbs pre-exercise and consulting with a registered dietitian if fatigue persists. Insurance coverage is a challenge—but not the end. Generic options (like liraglutide/Victoza via Mark Cuban Cost Plus Drugs), manufacturer programs, and “cocktail” regimens can support continued progress, even if you lose access to top-brand GLP-1s. Feedback loops & genetics drive lasting outcomes. While some patients can successfully—slowly—taper medications, most with metabolic dysfunction will need long-term support. “Clean eating” alone rarely reverses underlying feedback loop glitches. Monitoring is powerful. Using blood sugar monitors (especially for diabetics) can demystify meal spikes and help fine-tune nutrition and medication timing. Personal stories reflect broader truths. Listeners share struggles and solutions, reinforcing that metabolic health spans medication, motivation, and mindset.Dr. Cooper's Actionable TipsAlways dig deeper with testing—not just A1C but also post-meal spikes via the Mixed Meal Tolerance Test.If you're prescribed a GLP-1 and struggle with energy, increase carb intake safely and talk to a doctor about medication adjustment. For lost coverage, stick to FDA-approved sources: Lilly Direct for Zepbound, Novocare for Wegovy, and Mark Cuban for generics. Don't risk unregulated online compounds. Recognize the difference between generalized “healthy” habits and targeted strategies that actually move your biomarkers.Stay consistent and compassionate—focus on small improvements over extremes and absolutes.Notable Quote“The metabolism is regulated by a feedback loop…when you introduce outside hormone forms, you strengthen signals to favor fuel utilization over energy conservation.”— Dr. Emily CooperLinks & ResourcesPodcast Home: Fat Science Podcast WebsiteSubmit a Show Question: questions@fatsciencepodcast.com or dr.c@fatsciencepodcast.comDr. Emily Cooper on LinkedInMark Wright on LinkedInAndrea Taylor on InstagramGeneric medication access: Mark Cuban Cost Plus DrugsZepbound direct: Lilly DirectAdditional info: Novocare for WegovyFat Science is your source for breaking diet myths and advancing the science of true metabolic health. No diets, no agendas—just science that makes you feel better. The show is informational only and does not constitute medical advice.
In this episode of the Oncology Brothers podcast, we dived into the exciting world of cancer treatment with a focus on the recent FDA approval of Ziftomenib for relapsed refractory NPM1 mutated acute myeloid leukemia (AML). We were joined by Dr. Eunice Wang from Roswell Park Comprehensive Cancer Center as our guest. Dr. Wang shared insights from the KOMET-001 study, detailing the study design, efficacy, and safety profile of Ziftomenib. With a response rate of nearly 30% and significant overall survival benefits for patients, this new treatment option is a promising step forward in managing heavily pretreated AML. Key topics covered in this episode included: The mechanism of action of Ziftomenib as a menin inhibitor Study findings from KOMET-001 and patient response rates Management of side effects, including differentiation syndrome and QTc prolongation Comparison with other menin inhibitors like Revumenib Future directions for combination therapies and sequencing of treatments Whether you're a healthcare professional, a patient, or simply interested in the latest advancements in cancer therapy, this episode is packed with valuable information. Follow us on social media: X/Twitter: https://twitter.com/oncbrothers Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Don't forget to like, subscribe, and check out our other episodes for more insights into FDA approvals, toxicity management, and practice-changing conference highlights. #Ziftomenib #MeninInhibitor #AML #NPM1 #Leukemia #FDAapproval #OncologyBrothers
Want a legal career blending Intellectual Property (IP), Biotechnology, and Business? We sit down with Jenna Matheny (Vice-President & Managing Director at APIOiX) to break down the path to a high-impact career in medical innovation. This episode is essential listening for law students and those interested in patent law who also have a passion for science, revealing a world of opportunities beyond traditional law firm life.In this episode, we discuss:The Innovation Lifecycle: How lawyers are involved from invention disclosure and patent strategy to regulatory approval (FDA) and commercialization.The Business of IP: The critical, often-overlooked importance of contracting and compliance in developing and licensing medical technology.Finding Your Niche: Jenna's unique career path through university Tech Transfer offices, incubators, and accelerators—and how law students can get their foot in the door.Beyond Science: The growing field of social innovation and how non-science majors can find rewarding IP careers focused on copyright and trademark.Practical Law School Advice: Which broad-based courses (like securities and international tax) set you up for success, and the value of clinics and residencies.(00:00) - Introduction: Blending Law, Science, and Business in an IP Career (01:43) - Meet Jenna Matheny: Expert in Medical Technology IP and Tech Consulting (04:28) - Defining Biotech vs. MedTech: Law's Role in FDA Approval (05:42) - The Core Practice Areas: Patents, Contracting, and Regulatory Compliance (10:09) - Career Pivot: From Medicine Interest to Patent Attorney Path (11:32) - Tech Transfer Offices (TTOs): How Law Students Can Gain Experience (14:28) - Incubators & Accelerators: Consulting and Internship Roles for Attorneys (20:39) - Practical Advice: Essential Law School Courses (Securities, Tax) and Clinics (24:26) - Serendipity & Networking: How Connections Change the Course of a Legal Career (25:59) - Social Innovation: IP Opportunities without a Science Background (Copyright & Trademark) Click here to view the episode transcript.
© 2020-2025 Ivy Podcast Discovery LLC
